Global Concussions Market Research Report Forecast to 2023




Global Concussions Market Information: by Diagnosis & Treatment (Diagnosis, Treatment), End User (Hospitals and Clinics, Diagnostic Centers, Payers, Others), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) – Forecast till 2023
Market analysis

Head wounds that are extreme enough to influence cerebrum capacities are named as traumatic brain injuries (TBI). A blackout or concussion is a type of mellow traumatic head wounds. Rising instances of concussion combined with the developing item improvement for the administration of concussion by a few organizations have prompted the development of the global concussions market as of late. Furthermore, the developing geriatric populace is likewise expected to fuel the development of the market. In any case, the absence of a prepared workforce in various creating and immature economies is probably going to hamper the market development over the estimated time frame. As indicated by a paper distributed by the National Center for Biotechnology Information (NCBI) in March 2015, roughly 42 million individuals all inclusive endure mild traumatic brain injury (MTBI) or concussion consistently. Consequently, the expanding rate of concussions is relied upon to give ideal foundations to the market to develop over the figure time frame. The Global Concussions Market is projected to register a growth rate of CAGR 3.22% to reach the value of USD 1,060.4 million until the year 2023.

Market segmentation

The global concussions market is segmented on the basis of its Diagnosis & Treatment, end-user, and regional demand. On the basis of its Diagnosis & Treatment, the global concussions market is bifurcated as Treatment and Diagnosis. Based on its end-user, the global concussions market is divided into Diagnostic Centers, Hospitals and Clinics, Payers, Others.

Regional analysis

Geographically, the global concussions market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sun Pharmaceutical Industries Ltd, Medtronic Plc, Integra LifeSciences Corporation, and Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis AG, Mylan N.V., Pfizer, Inc., Zydus Cadila, Lupin, among others are some of the major players in the global concussions market.

Table of Contents

Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Overview
4.2 Drivers
4.2.1 Increasing Incidence of Mild Traumatic Brain Injuries
4.2.2 Ongoing Product Development and Approval
4.2.3 Growing Geriatric Population
4.3 Restraints
4.3.1 Stringent Regulatory Framework
4.3.2 Shortage of Trained Professionals
4.4 Opportunities
4.4.1 Growing Awareness about Concussions
5 Market Factor Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Services
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Concussions Market by Diagnosis & Treatment
6.1 Overview
6.2 Diagnosis
6.3 Treatment
7 Global Concussions Market, by End User
7.1 Overview
7.2 Hospitals and Clinics
7.3 Diagnostic Centers
7.4 Payers
8 Global Concussions Market, by Region
8.1 Overview
8.2 Americas
8.2.1 North America US Canada
8.2.2 Latin America
8.3 Europe
8.3.1 Western Europe Germany France UK Italy Spain Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
9 Competitive Landscape
9.1 Competitive Scenario
9.2 Prominent Players in the Concussion Therapeutics Industry
9.3 Prominent Players in the Concussion Diagnostic Industry
9.4 Key Developments
10 Company Profile
10.1 Teva Pharmaceutical Industries Ltd
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products/Services Offered
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.1.6 Key Strategies
10.2 Integra LifeSciences Corporation
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products Offering
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.2.6 Key Strategies
10.3 Medtronic Plc
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products Offering
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.3.6 Key Strategies
10.4 Sun Pharmaceutical Industries Ltd
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products/Services Offered
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.4.6 Key Strategies
10.5 Lupin
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products/Services Offered
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.5.6 Key Strategies
10.6 Zydus Cadila
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products/Services Offered
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.6.6 Key Strategies
10.7 Pfizer, Inc.
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products/Services Offered
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Key Strategies
10.8 Mylan N.V.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products/Services Offered
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.8.6 Key Strategies
10.9 Novartis AG
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products/Services Offered
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.9.6 Key Strategies
10.1 Sanofi S. A.
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products/Services Offered
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.10.6 Key Strategies
11 Appendix
11.1 References
11.2 Related Reports

Additional information


Geography Covered

Date Published